Rare Cancers – more common than you think
ESMO Video Commentary:
Personalised medicine in head and neck cancers
More than 4.3 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 198 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU28 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
24 Feb 2017
Study reveals PGK1 enzyme as therapeutic target for deadliest brain cancer
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma
17 Jan 2017
Post-Graduate Master Course: clinical oncology of rare solid tumours in adults
The University of Milan is hosting a Master Course for clinical oncologists interested in advancing their skills on rare adult solid cancers
13 Jan 2017
European policy response to rare cancers: the case of sarcoma
The European Commission, the European Parliament, experts and patients putting sarcoma on the political agenda